Clinical Trials on Patients With Moderate or Severe COVID-19 in Mexico
Total 28 results
-
Instituto Nacional de Ciencias Medicas y Nutricion...TerminatedPatients With Fungic InfectionsMexico
-
Grupo Cooperativo de Hemopatías MalignasCompletedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2Mexico
-
Hospital Central MilitarCompletedSevere COVID-19 DiseaseMexico
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
Instituto Nacional de Enfermedades RespiratoriasTerminatedCOVID-19 | Pneumonia, Viral | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome) | ARDS, Human | SARS PneumoniaMexico
-
National Institute of Respiratory Diseases, MexicoCompletedSevere Acute Respiratory Syndrome | COVID-19Mexico
-
National Institute of Respiratory Diseases, MexicoCompletedSevere Acute Respiratory Syndrome | COVID-19Mexico
-
Instituto Nacional de Enfermedades RespiratoriasUnknownCoronavirus Infection | Covid19 | AKI | SARS (Severe Acute Respiratory Syndrome)Mexico
-
Inovio PharmaceuticalsAdvaccine (Suzhou) Biopharmaceuticals Co., Ltd.TerminatedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Infection | COVID-19 DiseaseUnited States, Mexico, Colombia
-
InflaRx GmbHCompletedSevere COVID-19 PneumoniaBelgium, Brazil, France, Germany, Mexico, Netherlands, Peru, Russian Federation, South Africa
-
Corporacion Parc TauliInstitut de Ciències Fotòniques (ICFO); Centre de Recerca Matemàtica; Institute...RecruitingCovid19 | ARDS, HumanSpain, Mexico, Brazil
-
Instituto Nacional de Ciencias Medicas y Nutricion...Unknown
-
Grupo Mexicano para el Estudio de la Medicina IntensivaCompleted
-
Instituto Nacional de Cancerologia de MexicoCompletedPhase II Clinical Trial | Ninety-six Histologically Confirmed NSCLC Patients With BM | Randomized 1:1 to Received TN Plus WBR or Only WBR | ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRIMexico
-
Instituto de Medicina RegenerativaActive, not recruitingCovid-19 | ARDS, HumanMexico
-
Rigel PharmaceuticalsCompletedPneumonia, Viral | Pneumonia | Covid19 | SARS (Severe Acute Respiratory Syndrome) | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS PneumoniaUnited States, Argentina, Brazil, Mexico
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada
-
Synairgen Research Ltd.CompletedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
-
Abraham Edgar Gracia-RamosNational Polytechnic Institute, MexicoCompletedCOVID-19 | Respiratory Insufficiency | Respiratory Distress Syndrome, Adult | TelmisartanMexico
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
NovavaxDepartment of Health and Human ServicesCompletedCovid19 | SARS-CoV InfectionUnited States, Mexico, Puerto Rico
-
Regeneron PharmaceuticalsCompletedCOVID-19United States, Mexico, Romania, Brazil, Chile, Moldova, Republic of
-
Grifols Therapeutics LLCTerminatedCOVID-19United States, Brazil, Chile, Colombia, Mexico
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingHeart Failure | Pain | Pneumonia | Hypertension | Edema | Hemophilia | Insomnia | Pulmonary Arterial Hypertension | Coagulation Disorder | Asthma in Children | Down Syndrome | Attention Deficit Hyperactivity Disorder | Bronchopulmonary Dysplasia | Hypokalemia | Hyperphosphatemia | Primary Hyperaldosteronism | Adrenal Insufficiency and other conditionsUnited States, Canada